Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel.

PubWeight™: 3.39‹?› | Rank: Top 1%

🔗 View Article (PMID 11564488)

Published in Lancet on September 08, 2001

Authors

A Jouvenceau1, L H Eunson, A Spauschus, V Ramesh, S M Zuberi, D M Kullmann, M G Hanna

Author Affiliations

1: University Department of Clinical Neurology, Institute of Neurology, University College London, Queen Square, WC1N 3BG, London, UK.

Associated clinical trials:

4-Aminopyridine in Episodic Ataxia Type 2 (4AP in EA2) | NCT01543750

Articles citing this

Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest (2008) 1.81

Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Na(v)1.5 α-subunits. Cardiovasc Res (2012) 1.74

CaV2.1 channelopathies. Pflugers Arch (2010) 1.58

Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia (2010) 1.51

The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev (2015) 1.38

Human epilepsy, episodic ataxia type 2, and migraine. Lancet (2002) 1.38

Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast (2011) 1.29

Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol (2012) 1.28

The primary headaches: genetics, epigenetics and a behavioural genetic model. J Headache Pain (2008) 1.21

The role of positive selection in determining the molecular cause of species differences in disease. BMC Evol Biol (2008) 1.11

Long-term prognosis for childhood and juvenile absence epilepsy. J Neurol (2004) 1.10

Role of voltage-gated calcium channels in epilepsy. Pflugers Arch (2009) 1.08

SNAP-25 in neuropsychiatric disorders. Ann N Y Acad Sci (2009) 1.05

Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions. Eur J Hum Genet (2010) 1.00

Paroxysmal dyskinesias in mice. Mov Disord (2008) 0.99

Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. J Physiol (2010) 0.99

Large Genomic Deletions in CACNA1A Cause Episodic Ataxia Type 2. Front Neurol (2011) 0.98

Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy. J Neurol Neurosurg Psychiatry (2003) 0.97

Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am J Hum Genet (2003) 0.96

Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies. Neuroscience (2008) 0.95

Polymorphisms of the SCN1A gene in children and adolescents with primary headache and idiopathic or cryptogenic epilepsy: is there a linkage? J Headache Pain (2011) 0.95

Inherited Channelopathies Associated with Epilepsy. Epilepsy Curr (2004) 0.94

CaV 2.1 ablation in cortical interneurons selectively impairs fast-spiking basket cells and causes generalized seizures. Ann Neurol (2013) 0.94

Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias. F1000 Biol Rep (2010) 0.91

Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol (2015) 0.89

Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature. J Neurol (2014) 0.88

Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. J Bioenerg Biomembr (2003) 0.87

Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome. Hum Genet (2015) 0.87

In vivo analysis of voltage-dependent calcium channels. J Bioenerg Biomembr (2003) 0.87

Genetic regulation of human brain development: lessons from Mendelian diseases. Ann N Y Acad Sci (2010) 0.86

CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet (2015) 0.84

Dominant-negative suppression of Cav2.1 currents by alpha(1)2.1 truncations requires the conserved interaction domain for beta subunits. Mol Cell Neurosci (2006) 0.83

Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? Mol Autism (2013) 0.83

Canine epilepsy genetics. Mamm Genome (2011) 0.83

Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability. Eur J Hum Genet (2014) 0.83

Advances in imaging ultrastructure yield new insights into presynaptic biology. Front Cell Neurosci (2015) 0.80

Calcium channel dysfunction in inferior colliculus neurons of the genetically epilepsy-prone rat. Neuropharmacology (2008) 0.80

Novel mutation confirms seizure locus SCN1A is also familial hemiplegic migraine locus FHM3. Pediatr Neurol (2007) 0.80

CACNA1A and P/Q-type calcium channels in epilepsy. Lancet (2002) 0.79

The ataxic Cacna1a-mutant mouse rolling nagoya: an overview of neuromorphological and electrophysiological findings. Cerebellum (2009) 0.79

Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels. Front Cell Neurosci (2015) 0.78

Novel splice site CACNA1A mutation causing episodic ataxia type 2. Neurogenetics (2003) 0.78

The Revolution in Migraine Genetics: From Aching Channels Disorders to a Next-Generation Medicine. Front Cell Neurosci (2016) 0.78

A genetic interaction network model of a complex neurological disease. Genes Brain Behav (2014) 0.78

Interneuronal calcium channel abnormalities in posttraumatic epileptogenic neocortex. Neurobiol Dis (2011) 0.78

Redistribution of Cav2.1 channels and calcium ions in nerve terminals following end-to-side neurorrhaphy: ionic imaging analysis by TOF-SIMS. Histochem Cell Biol (2016) 0.77

T-type Ca2+ channels in absence epilepsy. Pflugers Arch (2014) 0.77

Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy. Prog Brain Res (2016) 0.76

Transcriptome analysis of neonatal larvae after hyperthermia-induced seizures in the contractile silkworm, Bombyx mori. PLoS One (2014) 0.76

Isolated P/Q Calcium Channel Deletion in Layer VI Corticothalamic Neurons Generates Absence Epilepsy. J Neurosci (2016) 0.76

Dysgraphia as a Mild Expression of Dystonia in Children with Absence Epilepsy. PLoS One (2015) 0.76

Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels. Neuroscience (2015) 0.75

GABAA Receptor Expression in the Forebrain of Ataxic Rolling Nagoya Mice. Biol Med (Aligarh) (2014) 0.75

Idiopathic generalized epilepsy and hypokalemic periodic paralysis in a family of South Indian descent. Case Rep Neurol Med (2015) 0.75

Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. Neurology (2016) 0.75

Dramatic Response After Lamotrigine in a Patient With Epileptic Encephalopathy and a De NovoCACNA1A Variant. Pediatr Neurol (2016) 0.75

In vivo impact of presynaptic calcium channel dysfunction on motor axons in episodic ataxia type 2. Brain (2016) 0.75

Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse. J Neurosci (2015) 0.75

A CaV2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant. Neurobiol Dis (2016) 0.75

The genetic relationship between epilepsy and hemiplegic migraine. Neuropsychiatr Dis Treat (2017) 0.75

Compromised maturation of GABAergic inhibition underlies abnormal network activity in the hippocampus of epileptic Ca2+ channel mutant mice, tottering. Pflugers Arch (2014) 0.75

Genetic and epigenetic mechanisms of epilepsy: a review. Neuropsychiatr Dis Treat (2017) 0.75

Articles by these authors

Shape, size, and distribution of Ca(2+) release units and couplons in skeletal and cardiac muscles. Biophys J (1999) 5.37

Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med (1999) 3.76

A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med (2014) 3.53

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet (1999) 3.25

The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24

Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain (2006) 3.16

Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87

Extrasynaptic glutamate diffusion in the hippocampus: ultrastructural constraints, uptake, and receptor activation. J Neurosci (1998) 2.78

Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol (1993) 2.50

Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med (1973) 2.31

Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest (1998) 2.29

Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron (1997) 2.27

Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis. J Clin Microbiol (2001) 2.23

Localization of 125I-labeled antigen in germinal centers of mouse spleen: histologic and ultrastructural autoradiographic studies of the secondary immune reaction. J Immunol (1968) 2.21

Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology (2006) 2.19

The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2005) 2.17

Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. J Exp Med (1974) 2.10

Cutaneous signs. Skinmed (2003) 2.04

Anaphylaxis secondary to levobupivacaine. Anaesthesia (2011) 2.02

Hippocampal synapses: do they talk to their neighbours? Trends Neurosci (1999) 1.98

Neurological channelopathies. Postgrad Med J (2005) 1.98

Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain (2012) 1.96

Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain (2007) 1.91

Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet (2000) 1.90

Transport of Ca2+ from sarcoplasmic reticulum to mitochondria in rat ventricular myocytes. J Bioenerg Biomembr (2000) 1.87

The ultrastructure of antigen localization and viruslike particles in mouse spleen germinal centers. Exp Mol Pathol (1968) 1.86

A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84

Reversible immunocontraception in male monkeys immunized with eppin. Science (2004) 1.84

Electron microscopic autoradiography of germinal center cells in mouse spleen. J Cell Biol (1965) 1.78

NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem (1998) 1.75

Geometric and viscous components of the tortuosity of the extracellular space in the brain. Proc Natl Acad Sci U S A (1998) 1.75

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71

Activation of AMPA, kainate, and metabotropic receptors at hippocampal mossy fiber synapses: role of glutamate diffusion. Neuron (1998) 1.68

The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev (1997) 1.67

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain (2009) 1.65

Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol (2000) 1.64

Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet (1994) 1.63

Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet (1994) 1.62

Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins. Neurology (2010) 1.59

Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population. Indian J Med Res (2008) 1.58

A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res (2000) 1.58

Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat (1999) 1.57

Comparative ultrastructure of Ca2+ release units in skeletal and cardiac muscle. Ann N Y Acad Sci (1998) 1.54

Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One (2010) 1.54

Tissue grafts in vitiligo surgery - past, present, and future. Indian J Dermatol (2009) 1.51

Investigation of gyrate atrophy using a cDNA clone for human ornithine aminotransferase. DNA (1986) 1.50

Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. Virology (1975) 1.48

Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J Natl Cancer Inst (1972) 1.48

Monosynaptic GABAergic signaling from dentate to CA3 with a pharmacological and physiological profile typical of mossy fiber synapses. Neuron (2001) 1.48

NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol (2001) 1.47

Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. J Natl Cancer Inst (1972) 1.47

Association of mammalian trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF. J Biol Chem (2000) 1.46

Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46

catena-Poly[ammonium (cadmium-tri-μ-thio-cyanato-κS:N;κN:S)-1,4,10,13,16-hexa-oxa-cyclo-octa-decane (1/1)]. Acta Crystallogr Sect E Struct Rep Online (2012) 1.45

How useful is the Mantoux test in the diagnosis of doubtful cases of cutaneous tuberculosis? Int J Dermatol (2011) 1.42

Eponyms in dermatology. Skinmed (2004) 1.41

Cutaneous leishmaniasis in Nepal: Leishmania major as a cause. Trans R Soc Trop Med Hyg (2008) 1.41

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet (2001) 1.39

Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma. Cancer Res (1972) 1.39

The B1 subunit of the H+ATPase is a PDZ domain-binding protein. Colocalization with NHE-RF in renal B-intercalated cells. J Biol Chem (2000) 1.39

Localized lepromatous leprosy and its response to chemo-immunotherapy. Int J Dermatol (1994) 1.39

The intricacies of research work. Indian J Dent Res (2010) 1.38

Letter to the editors. Secondary or reinfection cutaneous tuberculosis. Trop Med Int Health (2007) 1.38

Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies. J Postgrad Med (1998) 1.37

The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology (2010) 1.36

Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet (1993) 1.34

Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer (1996) 1.34

Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol (1995) 1.32

Effects of freezing on marrow stem cell suspensions: interactions of cooling and warming rates in the presence of PVP, sucrose, or glycerol. Cryobiology (1970) 1.30

Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. J Immunol (1972) 1.30

Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner. Cell Death Differ (2010) 1.29

Coats' plus: a progressive familial syndrome of bilateral Coats' disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument. Neuropediatrics (2004) 1.29

Skin tuberculosis in children: learning from India. Dermatol Clin (2008) 1.28

Kainate receptor-dependent axonal depolarization and action potential initiation in interneurons. Nat Neurosci (2001) 1.27

The effect of antigen competition on both the primary and secondary immune capacity in mice. J Immunol (1970) 1.27

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. PLoS Negl Trop Dis (2012) 1.27

Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infect (2013) 1.26

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer (1985) 1.25

Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology (1995) 1.24

Modulation of GABAergic signaling among interneurons by metabotropic glutamate receptors. Neuron (2000) 1.24

Tethering of the vertebral artery in the congenital arcuate foramen of the atlas vertebra: a possible cause of vertebral artery dissection in children. Dev Med Child Neurol (2001) 1.23

The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene (1996) 1.22

Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. Brain (2007) 1.21

Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2. Ann Hum Genet (1999) 1.21

Constancy of central conduction delays during development in man: investigation of motor and somatosensory pathways. J Physiol (1991) 1.21

Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscul Disord (2010) 1.21

Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res (1994) 1.20

A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy. Am J Hum Genet (1999) 1.20

Evaluation of the usefulness of Treponema pallidum hemagglutination test in the diagnosis of syphilis in weak reactive Venereal Disease Research Laboratory sera. Indian J Sex Transm Dis (2012) 1.20

What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed. Neurology (2008) 1.19